Trial Profile
Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Anovulation
- Focus Therapeutic Use
- Sponsors GeneScience Pharmaceuticals
- 17 Mar 2015 New trial record